Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: J Urol. 2009 Apr 17;181(6):2806–2815. doi: 10.1016/j.juro.2009.01.096

Figure 1.

Figure 1

Mean ICP/BP in 5 retired breeder rats treated with 100 µg pVAX, pVAX-hSlo and pSMAA-hSlo, respectively. Animals treated with pVAX-hSlo or pSMAA-hSlo showed significant ICP/BP increase in response to cavernous nerve stimulation with 0.75 or 4 mA compared to that in controls treated with empty plasmid vector pVAX. Asterisk indicates p <0.05.